Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  dinutuximab
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Isotretinoin with or without Dinutuximab, Aldesleukin, and Sargramostim following Stem Cell Transplant in Treating Patients with Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 30 and under at diagnosis
Trial IDs: ANBL0032, NCI-2009-01064, CDR0000069018, COG-ANBL0032, COG-P9842, NCT00026312
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin in Treating Patients With High-Risk Neuroblastoma Previously Treated With High-Dose Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 8 and under
Trial IDs: DIV-NB-201, NCI-2012-01336, CDR0000733747, 9347, NCT01592045
Irinotecan Hydrochloride and Temozolomide with Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Children
Trial IDs: ANBL1221, NCI-2012-03125, CDR0000745188, COG-ANBL1221, NCT01767194
Lenalidomide and Dinutuximab with or without Isotretinoin in Treating Younger Patients with Refractory or Recurrent Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and under
Trial IDs: NANT 2011-04, NCI-2012-02011, CDR0000741991, N2011-04, NANT 11-04, NANT N2011-04, NCT01711554
Start Over